The starting age dropped, a blood test joined the list, and there's now an age doctors say to quit.

We thank João Martins and Aneel Bhangu, Hermann Brenner and colleagues, and Uri Ladabaum and colleagues for their interesting comments on our report from the NordICC trial.1 We agree with Martins and ...

It's a rite of passage we don't look forward to: Once we turn 45, it's recommended that we get a colonoscopy to screen for polyps and colon cancer. This is especially important as rates of the disease ...

Researchers from Kaiser Permanente Northern California reveal that adults aged 45 to 49 undergoing their first screening colonoscopy have neoplasia detection rates similar to those aged 50 to 54, ...

Stool-based colorectal cancer (CRC) screening involves a two-step approach for those with a positive test that includes a ...

Nervous about getting a colonoscopy? A gastroenterologist answers six common questions about prep, the procedure, and what to expect.

For years, the gold standard in screening for colon cancer has been a colonoscopy. But a colonoscopy is a medical procedure that involves length prep work, along with being put under, making it ...

Tens of millions of middle-aged and older Americans haven't gotten their recommended checks for early signs of potential colon cancer, either through the "gold standard" of colonoscopy or a ...

Please provide your email address to receive an email when new articles are posted on . Among all the CRC screening methods, CRC incidence and mortality rates were highest among those who received ...

To reduce the burden of colorectal cancer (CRC), many countries like Germany support a policy of two screening colonoscopies 10 years apart. A new modelling study from Germany indicates that, holding ...

People receiving blood-based colorectal screening tests showed disappointingly low rates of receiving follow-up colonoscopies that are essential when tests are abnormal, with follow-up rates as low as ...

Michal F Kaminski and colleagues report that colonoscopy screening reduced colorectal cancer incidence, but not mortality, during a 13-year follow-up.1 The response from the public health field will ...